Contents

Recent Patents on Anti-Cancer Drug Discovery, Volume 4 - Number 2

Yeast-Derived β-Glucan in Combination with Anti-Tumor Monoclonal Antibody Therapy in Cancer

, 4(2): 101 - 109

Jingjing Liu, Lacey Gunn, Richard Hansen and Jun Yan


DOI: 10.2174/157489209788452858




Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression

, 4(2): 110 - 124

Yu-Wen E. Chang, Ronald R. Bean and Rolf Jakobi


DOI: 10.2174/157489209788452830




Ras-MAPK Pathway as a Therapeutic Target in Cancer - Emphasis on Bladder Cancer

, 4(2): 125 - 136

Pankaj P. Dangle, Boriana Zaharieva, Hongtao Jia and Kamal S. Pohar


DOI: 10.2174/157489209788452812




Paving Roads for New Drugs in Oncology

, 4(2): 137 - 145

Kurt S. Zaenker and Frank Entschladen


DOI: 10.2174/157489209788452795




Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma

, 4(2): 146 - 156

Emmanuel Seront and Jean-Pascal Machiels


DOI: 10.2174/157489209788452803




Selective Cyclooxygenase-2 (COX-2) Inhibitors Used for Preventing or Regressing Cancer

, 4(2): 157 - 163

Ricardo de Souza Pereira


DOI: 10.2174/157489209788452849




Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics

, 4(2): 164 - 173

Tai-Sung Lee, Steven J. Potts and Maher Albitar


DOI: 10.2174/157489209788452867




Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer

, 4(2): 174 - 179

Anil Kamath, Dal Yoo, Oswald A. Stuart, Lana Bijelic and Paul H. Sugarbaker


DOI: 10.2174/157489209788452876




Anti-Angiogenic Agents and Cancer: Current Insights and Future Perspectives

, 4(2): 180 - 185

Boel De Paepe


DOI: 10.2174/157489209788452821




Patent Selections

, 4(2): 186 - 188

Bentham Science Publishers


DOI: 10.2174/157489209788452885




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science